Lacosamide Solution
Product Images NDC 68094-076

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 68094-076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical structure diagram of Lacosamide, showing its molecular architecture including functional groups and atoms arranged in a distinct pattern characteristic of the active ingredient Lacosamide.*

FDA Label Image

Figure 1 (Lacosamide 02)

Bar chart showing seizure reduction median percentage change from baseline for placebo and lacosamide at various doses (200, 400, 600 mg/day) across three studies (Study 2, Study 3, Study 4). The chart compares efficacy, indicating higher seizure reduction percentages for lacosamide doses versus placebo in all studies.*

FDA Label Image

Figure 2 (Lacosamide 03)

A graph showing responder rates indicating improvement or worsening against percent of patients for Lacosamide oral solution. The plot compares placebo and Lacosamide doses of 200 mg/day, 400 mg/day, and 600 mg/day, with lines representing each group and patient counts provided in the legend.*

FDA Label Image

Figure 3 (Lacosamide 04)

A Kaplan-Meier survival curve showing the proportion of patients remaining on treatment over time (days) comparing Lacosamide and placebo groups. The graph includes risk reduction statistics and confidence intervals, with numbers at risk displayed below the time axis for each group.*

FDA Label Image

Principal Display Panel (5 mL Cup Label)

Lacosamide Oral Solution 50 mg per 5 mL vial label by Precision Dose, Inc. The label displays dosage form as oral solution and instructs to deliver 5 mL, with storage conditions of 20° to 25°C. It includes a caution for phenylketonurics regarding phenylalanine content and is marked Rx Only.*

FDA Label Image

Principal Display Panel (10 mL Cup Label)

Label of Lacosamide Oral Solution USP 100 mg/10 mL by Precision Dose, Inc., showing the dosage form as oral solution. The label indicates storage instructions (20° to 25°C), and notes that it is prescription only. It also contains a warning for phenylketonurics about phenylalanine content equivalent to 0.25 mg per 10 mL dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.